DropGenie

DropGenie is a functional biology company generating decision-ready discovery data from patient-derived cells. From its funding announcement.

$5M SeedRaised 2 days agoCambridge, USABiotech & PharmaUSA
Visit website →

In their own words

What DropGenie says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "functional biology company generating decision-ready discovery data from patient-derived cells". Source

Market expansionProductResearch and developmentCommercial growth

Public signal Read from the company's own description of what the funding supports.

Why now

Where DropGenie is today

DropGenie announced a funding round of $5M on 26 October 2026.

Latest round
Seed
Amount
$5M
Announced
26 October 2026
Headquarters
Cambridge, USA
Sector
Biotech & Pharma
Investors
Not stated
Also participating
Not stated
Relevant leadership
CEO Alison Hirukawa

Momentum AfterRaise intelligence

AfterRaise Score

58
Steady growth
1 funding signal in the last 90 days
Funding recency
40/40
announced within the last 30 days
Round scale
8/25
round size relative to the market
Funding stage
10/20
Seed
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 26 October 2026
    $5M Seed
    Investors not stated in the announcement.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • New market entry
  • First local hires in the new market
  • Local entity and legal setup
  • Product launches and new tiers

Opportunities this could create

  • Clinical operations
  • Scientific hiring
  • Licensing and BD partnerships
  • Market-entry advisers
  • Local employment infrastructure

Based on the Biotech & Pharma sector, a Seed round and the priorities the company itself set out. Not a statement of fact.

High momentum5 connected signals
  • 26 October 2026$5M Seed announced
  • 26 October 2026Stated priority: market expansion
  • 26 October 2026Stated priority: product
  • 26 October 2026Stated priority: research and development
  • 26 October 2026Stated priority: commercial growth

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What DropGenie is open to

Not yet specified

DropGenie has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with DropGenie

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at DropGenie?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: the roles and projects you have open. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Biotech & Pharma companies

See the sector